190 related articles for article (PubMed ID: 19687096)
1. A CD26-controlled cell surface cascade for regulation of T cell motility and chemokine signals.
Liu Z; Christensson M; Forslöw A; De Meester I; Sundqvist KG
J Immunol; 2009 Sep; 183(6):3616-24. PubMed ID: 19687096
[TBL] [Abstract][Full Text] [Related]
2. The role of CD26/DPP IV in chemokine processing.
Van Damme J; Struyf S; Wuyts A; Van Coillie E; Menten P; Schols D; Sozzani S; De Meester I; Proost P
Chem Immunol; 1999; 72():42-56. PubMed ID: 10550929
[No Abstract] [Full Text] [Related]
3. Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family.
Ajami K; Abbott CA; Obradovic M; Gysbers V; Kähne T; McCaughan GW; Gorrell MD
Biochemistry; 2003 Jan; 42(3):694-701. PubMed ID: 12534281
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in hematopoiesis.
Broxmeyer HE
Curr Opin Hematol; 2008 Jan; 15(1):49-58. PubMed ID: 18043246
[TBL] [Abstract][Full Text] [Related]
5. Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.
Bergström SE; Uzunel M; Talme T; Bergdahl E; Sundqvist KG
Immunology; 2015 Apr; 144(4):687-703. PubMed ID: 25393517
[TBL] [Abstract][Full Text] [Related]
6. Thymocyte selection: chemokine signaling is not only about the destination.
Gleimer M; von Boehmer H
Curr Biol; 2010 Apr; 20(7):R316-8. PubMed ID: 20392421
[TBL] [Abstract][Full Text] [Related]
7. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function.
Ohnuma K; Dang NH; Morimoto C
Trends Immunol; 2008 Jun; 29(6):295-301. PubMed ID: 18456553
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
9. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
[TBL] [Abstract][Full Text] [Related]
10. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli.
Cho HJ; Lee Y; Chang RS; Hahm MS; Kim MK; Kim YB; Oh YK
Protein Expr Purif; 2008 Jul; 60(1):37-45. PubMed ID: 18455434
[TBL] [Abstract][Full Text] [Related]
11. A cytokine-controlled mechanism for integrated regulation of T-lymphocyte motility, adhesion and activation.
Bergström SE; Bergdahl E; Sundqvist KG
Immunology; 2013 Dec; 140(4):441-55. PubMed ID: 23866045
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV.
Guan E; Wang J; Norcross MA
J Cell Biochem; 2004 May; 92(1):53-64. PubMed ID: 15095403
[TBL] [Abstract][Full Text] [Related]
13. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
Lim JK; Burns JM; Lu W; DeVico AL
J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218
[TBL] [Abstract][Full Text] [Related]
14. Chemokines: multiple levels of leukocyte migration control.
Moser B; Wolf M; Walz A; Loetscher P
Trends Immunol; 2004 Feb; 25(2):75-84. PubMed ID: 15102366
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration.
Liu KK; Dorovini-Zis K
J Neuroimmunol; 2009 Oct; 215(1-2):49-64. PubMed ID: 19765831
[TBL] [Abstract][Full Text] [Related]
16. Antibody-induced modulation of CD26 surface expression.
Mattern T; Reich C; Duchrow M; Ansorge S; Ulmer AJ; Flad HD
Immunology; 1995 Apr; 84(4):595-600. PubMed ID: 7790033
[TBL] [Abstract][Full Text] [Related]
17. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.
Mortier A; Gouwy M; Van Damme J; Proost P; Struyf S
J Leukoc Biol; 2016 Jun; 99(6):955-69. PubMed ID: 26744452
[TBL] [Abstract][Full Text] [Related]
18. CD26: a novel treatment target for T-cell lymphoid malignancies? (Review).
Sato K; Dang NH
Int J Oncol; 2003 Mar; 22(3):481-97. PubMed ID: 12579300
[TBL] [Abstract][Full Text] [Related]
19. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
20. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
